PKP3 and polycystic ovary syndrome: In line with this, overexpression of PKP3 in ovarian cancer A2780 cells contributes to a significant activation of the MAPK pathway [9] Inactivating the MAPK pathway can reduce the insulin resistance, which represents an obstacle in the treatment efficacy of PCOS [28].